Yip TC - Search Results

1

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.

Choi WM, Yip TC, Wong GL, Kim WR, Yee LJ, Brooks-Rooney C, Curteis T, Cant H, Chen CH, Chen CY, Huang YH, Jin YJ, Jun DW, Kim JW, Park NH, Peng CY, Shin HP, Shin JW, Yang YH, Lim YS. Choi WM, et al. Among authors: yip tc. J Hepatol. 2023 Mar;78(3):534-542. doi: 10.1016/j.jhep.2022.12.007. Epub 2022 Dec 23. J Hepatol. 2023. PMID: 36572349 Free article.

2

Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects.

Wong GL, Tse YK, Wong VW, Yip TC, Tsoi KK, Chan HL. Wong GL, et al. Among authors: yip tc. Hepatology. 2015 Sep;62(3):684-93. doi: 10.1002/hep.27894. Epub 2015 Jul 28. Hepatology. 2015. PMID: 25973979

3

Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.

Hsiang JC, Wong GL, Tse YK, Wong VW, Yip TC, Chan HL. Hsiang JC, et al. Among authors: yip tc. J Hepatol. 2015 Nov;63(5):1190-7. doi: 10.1016/j.jhep.2015.07.009. Epub 2015 Jul 21. J Hepatol. 2015. PMID: 26208777

4

Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

Yip TC, Chan HL, Wong VW, Tse YK, Lam KL, Wong GL. Yip TC, et al. J Hepatol. 2017 Nov;67(5):902-908. doi: 10.1016/j.jhep.2017.06.019. Epub 2017 Jun 24. J Hepatol. 2017. PMID: 28652084

5

Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance".

Yip TC, Chan HL, Wong VW, Wong GL. Yip TC, et al. J Hepatol. 2017 Sep 19:S0168-8278(17)32266-3. doi: 10.1016/j.jhep.2017.08.026. Online ahead of print. J Hepatol. 2017. PMID: 28870669 No abstract available.

6

Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study.

Subramaniam S, Wong VW, Tse YK, Yip TC, Chan HL, Wong GL. Subramaniam S, et al. Among authors: yip tc. J Gastroenterol Hepatol. 2018 Apr;33(4):934-941. doi: 10.1111/jgh.14003. Epub 2018 Jan 26. J Gastroenterol Hepatol. 2018. PMID: 28949045

7

Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients.

Yip TC, Wong GL, Wong VW, Tse YK, Lui GC, Lam KL, Chan HL. Yip TC, et al. J Hepatol. 2017 Oct 6:S0168-8278(17)32332-2. doi: 10.1016/j.jhep.2017.09.018. Online ahead of print. J Hepatol. 2017. PMID: 28989093

8

Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Liu K, Wong VW, Lau K, Liu SD, Tse YK, Yip TC, Kwok R, Chan AY, Chan HL, Wong GL. Liu K, et al. Among authors: yip tc. Am J Gastroenterol. 2017 Dec;112(12):1812-1823. doi: 10.1038/ajg.2017.389. Epub 2017 Oct 31. Am J Gastroenterol. 2017. PMID: 29087391

9

Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

Hsu YC, Yip TC, Ho HJ, Wong VW, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GL, Wu CY. Hsu YC, et al. Among authors: yip tc. J Hepatol. 2018 Aug;69(2):278-285. doi: 10.1016/j.jhep.2018.02.032. Epub 2018 Mar 16. J Hepatol. 2018. PMID: 29551708

10

Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.

Wong GL, Chan HL, Tse YK, Yip TC, Lam KL, Lui GC, Wong VW. Wong GL, et al. Among authors: yip tc. J Hepatol. 2018 Oct;69(4):793-802. doi: 10.1016/j.jhep.2018.05.009. J Hepatol. 2018. PMID: 29758335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page